Verrica Pharmaceuticals Inc.VRCANASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
12.93%
↓ 93% below average
Average (34q)
189.99%
Historical baseline
Range
High:3787.38%
Low:-134.40%
Volatility
2064.2%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 12.93% |
| Q2 2025 | 269.35% |
| Q1 2025 | 899.71% |
| Q4 2024 | 119.31% |
| Q3 2024 | -134.40% |
| Q2 2024 | 35.31% |
| Q1 2024 | 92.45% |
| Q4 2023 | -31.85% |
| Q3 2023 | 1502.75% |
| Q2 2023 | 391.89% |
| Q1 2023 | -45.59% |
| Q4 2022 | -99.18% |
| Q3 2022 | 3787.38% |
| Q2 2022 | -50.35% |
| Q1 2022 | 0.00% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | -100.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |